BNK Capital Group

IPO

IPO Snapshot

Curis Lifesciences Ltd.

Issue Open Date	07-Nov-25
Issue Closing Date	11-Nov-25
Application Money	100
Allotment Money

Price Band ()	120 - 128
Minimum Bid Quantity.	2000
Issue Size (Shares)	1541000
Market Lot	1

Objective

i.Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities ii.Capital Expenditure towards Construction of a Storage Facility iii.Pre-payment/Repayment of outstanding Secured Loans iv.Product Registrations in other countries v.Funding our Working Capital Requirements andvi.General Corporate Purpose.

Business Description

Our business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic onloan license or contract Manufacturing and own brand marketing basis. Our business is majorly on principle to principlebasis with different marketers. As on the date of this Draft Red Herring Prospectus, we cater to more than 100 corporateclients on loan license and/or contra...

Promoter's Holding

Total Share Capital	5500000
Offered to Public	1541000
Promoter's Holding (Pre-Issue)	92.68
Promoter's Holding (Post-Issue)	68.03

Address

Address :P F-23
G I D C
Sanand - I I
Industrial Estate
Sanand City :Ahmedabad, State :Gujarat Pincode :382110 Phone :7096558558 Email : info@curisls.com Website : www.curisls.com

Registrar

MUFG Intime India Pvt Ltd.
C 101
247 Park
LBS Marg
Vikhroli (West)
Mumbai

Listed at

NSE

Lead Manager

Finaax Capital Advisors Pvt Ltd

Promoters

Dharmesh Dashrathbhai Patel
Jaimik Mansukhbhai Patel
Piyush Gordhanbhai Antala
Siddhant Jayantibhai Pawasia

ATTENTION INVESTORS | KYC| IPO| UPI ID- stock broking services| UPI ID- depository services

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

BNK Securities Pvt. Ltd

CIN No.:U67120WB1995PTC071182 (ISO 90001:2015 & ISO 27001:2022 Certified Company)

Registered Office: Mayfair Tower, 2,Palm Avenue,Kolkata-700 019

Tel:+91-33-4602-2160/61/62/63 Email:contact@bnkcapital.com

BNK Securities Pvt Ltd. MEMBERS OF NSE, BSE AND MSEI SEBI Registration no: INZ000220037

SEBI Registration No: MB / INM000011641 (Category I Merchant Banker), Research Analyst. Reg no INH300003520

DEPOSITORY PARTICIPANT SEBI Registration No-In-DP-673-2022, CDSL DP ID - 12060500.

AMFI certified Mutual Fund Distributor Registration No: ARN–86507

For any grievances, investors can contact at: grievance@bnkstockline.com, Tel:+91-33-4602-2160/61/62/63

Sl.no	Name of the report	URL
1	Track Record of the public issues managed	https://www.bnkcapital.com/files/downloads/638702164788663094_Disclousure_of_Track_Record_of_the_public_issues_managed_by_Merchant_Bankers_for_the_Half_Yearly_period_-_Sep_2024.pdf
2	Investor Charter	https://www.bnkcapital.com/files/pdf/BNK-Investor-Charter.pdf
3	Disclosure of data on complaints (Investor grievances data)	https://www.bnkcapital.com/files/pdf/Investor-Complaints-Data-January-2025.pdf

BNK Capital

Open an Account

Open an Account

Registration Form

Login Form

IPO Snapshot